Home > News > Iran to make new breast cancer detector
August 2nd, 2009
Iran to make new breast cancer detector
Abstract:
Iranians have developed a new method using nanotechnology to detect breast cancer in its early stages with the aim of lowering its mortality rate.
"Like many other countries, Iranians have been trying to achieve new therapeutic and diagnostic methods to treat cancer patients," said the head of Avicenna Research Center, Mohammad-Mehdi Akhoundi.
He added that Avicenna institute researchers have succeeded in developing a new method to diagnose breast cancer using the safe and non-toxic nanotechnology.
In this method, monoclonal antibody Her-2, the anti-tumoral marker of breast cancer, is produced. Marked with nano-particles, these antibodies are then injected in the body in order to detect the affected tumoral tissues.
Akhoundi concluded that after undergoing animal trials, the new technique can be used to detect breast cancer in its early stages, providing sufferers with more effective therapeutic interventions.
Avicenna researchers have also developed new techniques to treat various cancers such as blood malignancies, many of which will enter the market as soon as their animal testing is complete.
Source:
presstv.ir
Related News Press |
News and information
Beyond wires: Bubble technology powers next-generation electronics:New laser-based bubble printing technique creates ultra-flexible liquid metal circuits November 8th, 2024
Nanoparticle bursts over the Amazon rainforest: Rainfall induces bursts of natural nanoparticles that can form clouds and further precipitation over the Amazon rainforest November 8th, 2024
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Nanomedicine
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Unveiling the power of hot carriers in plasmonic nanostructures August 16th, 2024
Discoveries
Breaking carbon–hydrogen bonds to make complex molecules November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
Announcements
Nanotechnology: Flexible biosensors with modular design November 8th, 2024
Exosomes: A potential biomarker and therapeutic target in diabetic cardiomyopathy November 8th, 2024
Turning up the signal November 8th, 2024
Nanofibrous metal oxide semiconductor for sensory face November 8th, 2024
The latest news from around the world, FREE | ||
Premium Products | ||
Only the news you want to read!
Learn More |
||
Full-service, expert consulting
Learn More |
||